Savolainen MJ - Search Results

1

Effect of hypertension, diabetes and other cardiovascular risk factors on kidney size in middle-aged adults.

Päivänsalo MJ, Merikanto J, Savolainen MJ, Lilja M, Rantala AO, Kauma H, Reunanen A, Kesäniemi YA, Suramo I. Päivänsalo MJ, et al. Among authors: savolainen mj. Clin Nephrol. 1998 Sep;50(3):161-8. Clin Nephrol. 1998. PMID: 9776419

2

Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype.

Savolainen MJ, Rantala M, Kervinen K, Järvi L, Suvanto K, Rantala T, Kesäniemi YA. Savolainen MJ, et al. Atherosclerosis. 1991 Feb;86(2-3):145-52. doi: 10.1016/0021-9150(91)90210-t. Atherosclerosis. 1991. PMID: 1872909

3

Multiple changes in apoprotein B containing lipoproteins after ethanol withdrawal in alcoholic men.

Kervinen K, Savolainen MJ, Kesäniemi YA. Kervinen K, et al. Among authors: savolainen mj. Ann Med. 1991 Oct;23(4):407-13. doi: 10.3109/07853899109148083. Ann Med. 1991. PMID: 1930937

4

Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity.

Savolainen MJ, Hannuksela M, Seppänen S, Kervinen K, Kesäniemi YA. Savolainen MJ, et al. Eur J Clin Invest. 1990 Dec;20(6):593-9. doi: 10.1111/j.1365-2362.1990.tb01906.x. Eur J Clin Invest. 1990. PMID: 2127749

5

Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus.

Ukkola O, Savolainen MJ, Salmela PI, von Dickhoff K, Kiema T, Kesäniemi YA. Ukkola O, et al. Among authors: savolainen mj. J Mol Med (Berl). 1995 Jun;73(6):307-11. doi: 10.1007/BF00231617. J Mol Med (Berl). 1995. PMID: 7583453

6

Effect of a synthetic prostaglandin E2 analogue, RS-86505-007, on plasma lipids and lipoproteins in patients with moderate hypercholesterolaemia: efficacy and tolerance of treatment and response in different apolipoprotein polymorphism groups.

Korhonen T, Savolainen MJ, Jääskeläinen T, Kesäniemi YA. Korhonen T, et al. Among authors: savolainen mj. Eur J Clin Pharmacol. 1995;48(2):97-102. doi: 10.1007/BF00192732. Eur J Clin Pharmacol. 1995. PMID: 7589035 Clinical Trial.

7

Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease.

Juvonen T, Savolainen MJ, Kairaluoma MI, Lajunen LH, Humphries SE, Kesäniemi YA. Juvonen T, et al. Among authors: savolainen mj. J Lipid Res. 1995 Apr;36(4):804-12. J Lipid Res. 1995. PMID: 7616125

8

DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus.

Ukkola O, Savolainen MJ, Salmela PI, von Dickhoff K, Kesäniemi YA. Ukkola O, et al. Among authors: savolainen mj. Atherosclerosis. 1995 May;115(1):99-105. doi: 10.1016/0021-9150(94)05504-c. Atherosclerosis. 1995. PMID: 7669092

9

DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus.

Ukkola O, Savolainen MJ, Salmela PI, von Dickhoff K, Kesäniemi YA. Ukkola O, et al. Among authors: savolainen mj. Clin Genet. 1994 Sep;46(3):217-27. doi: 10.1111/j.1399-0004.1994.tb04230.x. Clin Genet. 1994. PMID: 7820935

10

Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers.

Hannuksela ML, Liinamaa MJ, Kesäniemi YA, Savolainen MJ. Hannuksela ML, et al. Among authors: savolainen mj. Atherosclerosis. 1994 Sep 30;110(1):35-44. doi: 10.1016/0021-9150(94)90065-5. Atherosclerosis. 1994. PMID: 7857368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results